Image may be NSFW.
Clik here to view.
Clik here to view.
Ocutrx augmented reality headset helping AMD patients see clearly
Michael Freeman, Founder & President California-based Ocutrx Vision Technologies has developed an augmented reality (AR) headset that helps age-related macular degeneration (AMD) patients overcome...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Outlook Therapeutics completes enrollment in Phase 3 wet AMD trial
Outlook Therapeutics (NASDAQ:OTLK) completed patient enrollment in its Phase 3 clinical trial comparing ONS-5010 to ranibizumab for the treatment of wet age-related macular degeneration (AMD)....
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
LumiThera enrolls first patient in U.S. multi-center trial in dry AMD
Closely-held LumiThera enrolled the first patient in its multi-center U.S. clinical trial in patients with dry age-related macular degeneration (AMD). The study, called LIGHTSITE III, will evaluate...
View Article
More Pages to Explore .....
